Emergent Biosolutions (EBS) Tops Q2 EPS by 8c
Emergent Biosolutions (NYSE: EBS) reported Q2 EPS of $0.29, $0.08 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
